HI
HIMS.US Hims Hers Health Inc
- Market cap
- USD 4.62B
- P/E
- -
- P/B
- 13.02x
- ROE
- -79.3%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is HIMS.US undervalued?
Graham numberThe Graham number of Hims Hers Health Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Hims Hers Health Inc fundamental analysis
No fundamental analysis for Hims Hers Health Inc yet.
Hims Hers Health Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Hims Hers Health Inc
Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, Australia, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It als…
Full company profileHims Hers Health Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Hims Hers Health Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||
| Revenue | 26.7M | 82.6M | 149M | 272M | 527M | 872M | 1.48B | 2.35B | 3.00B |
| Gross Profit | 7.80M | 44.6M | 109M | 204M | 409M | 715M | 1.17B | 1.73B | 1.72B |
| Operating Income | -75.8M | -74.4M | -15.1M | -115M | -68.7M | -29.5M | 61.9M | 106M | -240M |
| EBITDA | - | -71.3M | -14.1M | -107M | -58.2M | -12.1M | 88.8M | 178M | -201M |
| Net Income | -75.2M | -72.1M | -18.1M | -108M | -65.7M | -23.5M | 126M | 128M | -282M |
| EPS | -1.12 | -2.07 | -0.51 | -0.58 | -0.32 | -0.11 | 0.53 | 0.50 | -1.21 |
| Balance Sheet | |||||||||
| Total Assets | 47.5M | 72.1M | 119M | 421M | 366M | 441M | 708M | 2.15B | 3.55B |
| Total Liabilities | 24.7M | 207M | 266M | 86.0M | 54.6M | 97.2M | 231M | 1.61B | 3.19B |
| Shareholders' Equity | 22.8M | -135M | -147M | 335M | 312M | 344M | 477M | 541M | 355M |
| Cash & Short-term Investments | 41.5M | 60.4M | 100M | 247M | 180M | 221M | 300M | 577M | 712M |
| Total Debt | 8.40M | 1.52M | - | 5.48M | 5.31M | 9.95M | 11.3M | 1.12B | 1.56B |
| Cash Flow | |||||||||
| Operating Cash Flow | -57.3M | -74.9M | -2.48M | -34.4M | -26.5M | 73.5M | 251M | 300M | 158M |
| Capital Expenditure | 8.00K | 1.79M | 4.23M | 5.01M | 7.25M | 26.5M | 52.8M | 226M | 119M |
| Free Cash Flow | -57.3M | -76.7M | -6.71M | -39.4M | -33.8M | 47.0M | 198M | 74.0M | 39.7M |
| Ratios | |||||||||
| ROE | -330.1% | - | - | -32.2% | -21.1% | -6.8% | 26.4% | 23.7% | -79.3% |
| ROA | -158.3% | -100.0% | -15.3% | -25.6% | -17.9% | -5.3% | 17.8% | 6.0% | -7.9% |
| Net Profit Margin | -282.0% | -87.3% | -12.2% | -39.6% | -12.5% | -2.7% | 8.5% | 5.5% | -9.4% |
| Debt to Equity | 0.37x | - | - | 0.02x | 0.02x | 0.03x | 0.02x | 2.07x | 4.39x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Hims Hers Health Inc dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | - | - | - |
| 2020 | USD 1.74M | 0.05 | - |
| 2019 | - | - | - |
| 2018 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Hims Hers Health Inc
- Insiders 6.95%
- Institutions 68.12%
- Public & others 24.93%
- Shares outstanding 226M
- Free float 215M
Top funds holding HIMS.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| iShares Core S&P Mid-Cap ETF | 7.60M | 3.24% | +0.05% | Oct 2026 |
| Vanguard MStar Total Stk Mkt Idx Invest | 6.75M | 2.88% | +0.27% | Sep 2026 |
| iShares Russell 2000 ETF | 5.48M | 2.34% | 0.00% | Oct 2026 |
| Vanguard Small Cap Index | 4.81M | 2.05% | -1.42% | Sep 2026 |
| Vanguard MStar Small Cap Growth Indx Inv | 2.68M | 1.14% | -4.29% | Sep 2026 |
| Fidelity Small Cap Index | 2.37M | 1.01% | +0.15% | Aug 2026 |
| iShares Russell 2000 Growth ETF | 2.03M | 0.87% | -0.38% | Oct 2026 |
| JPMorgan Large Cap Growth I | 1.96M | 0.84% | -0.91% | Sep 2026 |
| State Street® SPDR® S&P MIDCAP 400® ETF | 1.56M | 0.67% | +0.87% | Sep 2026 |
| Fidelity Small Cap Growth | 1.54M | 0.66% | +25.62% | Aug 2026 |
| iShares S&P Mid-Cap 400 Growth ETF | 1.27M | 0.54% | -0.26% | Oct 2026 |
| Vanguard Russell 2000 ETF | 1.26M | 0.54% | +1.14% | Sep 2026 |
| State Street SPDR Port S&P 400 Md CpETF | 1.15M | 0.49% | 0.00% | Oct 2026 |
| Schwab US Small-Cap ETF™ | 1.12M | 0.48% | +0.24% | Oct 2026 |
| Fidelity Extended Market Index | 973K | 0.41% | -5.95% | Sep 2026 |
| T. Rowe Price New Horizons | 905K | 0.39% | -19.85% | Sep 2026 |
| Fidelity Small Cap Growth K6 | 808K | 0.34% | +25.80% | Aug 2026 |
| BlackRock Advantage Small Cap Core Instl | 694K | 0.30% | +24.26% | Sep 2026 |
| Schwab US Mid-Cap ETF | 641K | 0.27% | +0.13% | Oct 2026 |
| Vanguard Health Care ETF | 613K | 0.26% | +0.11% | Sep 2026 |
Top institutions holding HIMS.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| BlackRock Inc | 28.7M | 12.25% | +8.98% | Jun 2026 |
| Vanguard Portfolio Management, LLC | 10.6M | 4.50% | +3.69% | Jun 2026 |
| Vanguard Capital Management, LLC | 9.54M | 4.07% | +2.16% | Jun 2026 |
| State Street Corp | 8.15M | 3.48% | +9.19% | Jun 2026 |
| Morgan Stanley - Brokerage Accounts | 7.15M | 3.05% | -19.54% | Jun 2026 |
| Divisadero Street Capital Management, LP | 6.01M | 2.56% | +1,179.07% | Jun 2026 |
| Geode Capital Management, LLC | 5.68M | 2.42% | +9.29% | Jun 2026 |
| The Goldman Sachs Group Inc | 5.17M | 2.21% | +110.77% | Jun 2026 |
| JPMorgan Chase & Co | 4.77M | 2.03% | -9.05% | Jun 2026 |
| FMR Inc | 4.32M | 1.84% | +4,535.24% | Jun 2026 |
| Marshall Wace Asset Management Ltd | 4.22M | 1.80% | +482.38% | Jun 2026 |
| UBS Group AG | 2.66M | 1.14% | -35.91% | Jun 2026 |
| Northern Trust Corp | 2.59M | 1.11% | +6.50% | Jun 2026 |
| Charles Schwab Investment Management Inc | 2.45M | 1.05% | +4.03% | Jun 2026 |
| Bank of America Corp | 2.31M | 0.99% | -46.94% | Jun 2026 |
| Vanguard Fiduciary Trust Co | 1.52M | 0.65% | +5.03% | Jun 2026 |
| Bank of New York Mellon Corp | 1.33M | 0.57% | -0.54% | Jun 2026 |
| State Treasurer State Of Michigan | 1.21M | 0.52% | -48.52% | Sep 2026 |
| Schroder Investment Management Group | 1.13M | 0.48% | +54.18% | Jun 2026 |
| CANTOR FITZGERALD, L. P. | 1.11M | 0.47% | +1.63% | Jun 2026 |
Hims Hers Health Inc company profile
- Company name
- Hims Hers Health Inc
- Ticker
- HIMS.US
- Exchange
- USA Stocks
- Listed since
- Sep 13, 2019
- Sector
- Healthcare
- Industry
- Health Care Providers & Services
- Employees
- 2,442
- Fiscal year end
- December
- Address
- 2269 Chestnut Street, San Francisco, CA, United States, 94123
- Phone
- 415 851 0195
- Website
- hims.com
About Hims Hers Health Inc
Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, Australia, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides personalized health and wellness products; over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, skincare, sexual health and wellness, and hair care under the Hims & Hers brand name; and laboratory testing services to measure a set of biomarkers. Additionally, it offers medical consultation, post-consultation support services, and delivery of laboratory testing results services. Further, the company provides treatments and products for various chronic conditions related to hormone health, weight loss, dermatology, and mental health. The company offers its products through retail partnerships, in stores, and online. The company was formerly known as Hims, Inc. and changed its name to Hims & Hers Health, Inc. in January 2021. The company was founded in 2017 and is based in San Francisco, California.
Hims Hers Health Inc management
10- Mr. Andrew DudumCo-Founder, Chairman & CEO · born 1988
- Mr. Oluyemi OkupeChief Financial Officer · born 1986
- Mr. Mike ChiChief Operating Officer · born 1980
- Mr. Mohamed ElShenawyChief Technology Officer · born 1975
- Ms. Soleil Teubner Boughton J.D.Chief Legal Officer & Corporate Secretary · born 1978
- Dr. Patrick Carroll M.D.Global Chief Medical Officer · born 1958
- Ms. Deborah M. Autor J.D.Chief Policy Officer & Director · born 1967
- Mr. Jonathan M. FranklinChief Accounting Officer & Principal Accounting Officer · born 1983
- Mr. William James NewbySenior Director of Investor Relations
- Ms. Kathryn H. Beiser B.A., M.S.Chief Communications Officer